Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
96.41 CHF | +1.01% |
|
-39.82% | -47.70% |
15.07. | Moderna-Insider verkauft Aktien im Wert von $1.756.177, laut einer aktuellen SEC-Einreichung | MT |
12.07. | China genehmigt den RSV-Impfstoff von CSPC Pharma für klinische Studien | RE |
Performance
1 Tag | +1.01% | ||
Aktueller Monat | -47.70% | ||
Laufendes Jahr | -47.70% |
Volumen
MärkteBasisdaten
Extremkurse
![Kursextrem 96.40800000](/images/extremecours_fleche.png)
![Kursextrem 96.40800000](/images/extremecours_fleche.png)
![Kursextrem 96.40800000](/images/extremecours_fleche.png)
Indikatoren
Sektorenvergleich - Biotechnologie und medizinische Forschung - Andere
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
+1.01% | -39.82% | -47.70% | - | 46.56 Mrd. | ||
-0.39% | +1.90% | +45.38% | -5.55% | 41.67 Mrd. | ||
+3.13% | +9.35% | +0.69% | +5.37% | 41.16 Mrd. | ||
-2.48% | -1.93% | +30.52% | +26.75% | 32.4 Mrd. | ||
+1.57% | +6.85% | +22.30% | +40.59% | 28.18 Mrd. | ||
0.00% | +0.80% | -6.35% | +19.28% | 28.1 Mrd. | ||
+0.28% | +1.72% | +49.25% | +41.46% | 14.52 Mrd. | ||
+2.88% | +11.28% | +49.18% | +88.02% | 13.74 Mrd. | ||
+3.38% | +11.97% | +3.45% | -5.22% | 12.17 Mrd. | ||
+5.11% | +12.61% | -3.85% | +9.52% | 11.14 Mrd. | ||
+1.84% | +6.27% | -4.92% | -10.27% | 9.27 Mrd. | ||
+1.67% | +6.49% | +63.08% | +75.43% | 7.59 Mrd. | ||
+0.81% | +4.56% | +30.64% | +109.17% | 7.48 Mrd. | ||
+1.67% | +0.06% | +31.23% | +12.09% | 7.03 Mrd. | ||
+4.77% | +5.95% | -1.48% | +17.33% | 6.94 Mrd. | ||
-.--% | -.--% | - | - | 6.07 Mrd. | ||
Durchschnitt | +1.58% | +5.02% | +17.43% | +30.28% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +1.10% | +4.88% | +11.04% | +22.56% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
- Börse
- Aktien
- A2N9D9 Aktie
- A2N9D9 Aktie
- Kurse Moderna, Inc.